Literature DB >> 2138890

Isolation and identification of human brain natriuretic peptides in cardiac atrium.

J Hino1, H Tateyama, N Minamino, K Kangawa, H Matsuo.   

Abstract

By using a radioimmunoassay (RIA) system newly established for human brain natriuretic peptide (BNP), a high concentration of immunoreactive (ir-) human BNP (hBNP) has been found in cardiac atrium (1). Two molecular forms of ir-hBNP of 4K and 13-15K were isolated from atrial extracts by using anti-hBNP IgG immunoaffinity chromatography and reverse phase high performance liquid chromatography (HPLC). By microsequencing, the peptides were determined to be a pro-hBNP (gamma-hBNP) and its C-terminal 32-amino acid peptide (hBNP-32). Based on these results, in cardiac atrium, hBNP is found to be processed in a pathway similar to that of porcine BNP (pBNP) but distinct from that of rat BNP, although low MW hBNP-32 is a major form in contrast to pBNP which exists as a high MW gamma-pBNP.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138890     DOI: 10.1016/0006-291x(90)92081-a

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Systems biology and heart failure: concepts, methods, and potential research applications.

Authors:  Kirkwood F Adams
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

Review 2.  Diverse molecular forms of plasma B-type natriuretic peptide in heart failure.

Authors:  Toshio Nishikimi; Naoto Minamino; Kazuwa Nakao
Journal:  Curr Heart Fail Rep       Date:  2011-06

3.  Immunohistochemical localisation of natriuretic peptides in the heart and brain of the gulf toadfish Opsanus beta.

Authors:  J A Donald; D H Evans
Journal:  Cell Tissue Res       Date:  1992-07       Impact factor: 5.249

Review 4.  Cardioprotective actions of peptide hormones in myocardial ischemia.

Authors:  Dwaine S Burley; Shabaz A Hamid; Gary F Baxter
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

5.  Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure.

Authors:  C Haug; A Metzele; J Steffgen; M Kochs; V Hombach; A Grünert
Journal:  Clin Investig       Date:  1994-06

6.  Ruling out cardiac failure: cost-benefit analysis of a sequential testing strategy with NT-proBNP before echocardiography.

Authors:  Maria-José Ferrandis; Ingvar Ryden; Tomas L Lindahl; Anders Larsson
Journal:  Ups J Med Sci       Date:  2012-12-12       Impact factor: 2.384

7.  Bone morphogenetic protein-3b (BMP-3b) is expressed in adipocytes and inhibits adipogenesis as a unique complex.

Authors:  J Hino; T Miyazawa; M Miyazato; K Kangawa
Journal:  Int J Obes (Lond)       Date:  2011-06-28       Impact factor: 5.095

8.  Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent.

Authors:  Brian Casserly; James R Klinger
Journal:  Drug Des Devel Ther       Date:  2009-12-29       Impact factor: 4.162

9.  Selenium in the prevention of anthracycline-induced cardiac toxicity in children with cancer.

Authors:  Nurdan Tacyildiz; Derya Ozyoruk; Guzin Ozelci Kavas; Gulsan Yavuz; Emel Unal; Handan Dincaslan; Semra Atalay; Tayfun Ucar; Aydan Ikinciogullari; Beyza Doganay; Gulsah Oktay; Ayhan Cavdar; Omer Kucuk
Journal:  J Oncol       Date:  2012-10-16       Impact factor: 4.375

10.  Influence of atrial natriuretic peptide, brain natriuretic peptide and urodilatin on the histamine-induced bronchoconstriction in the conscious guinea pig.

Authors:  M Hermel
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 5.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.